Efficacy and Safety Study of Topical Bromfenac Ophthalmic Solution vs. Placebo for Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery.

Trial Profile

Efficacy and Safety Study of Topical Bromfenac Ophthalmic Solution vs. Placebo for Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Feb 2013

At a glance

  • Drugs Bromfenac (Primary)
  • Indications Ocular inflammation; Ocular pain; Postoperative pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Bausch & Lomb
  • Most Recent Events

    • 08 Jun 2011 Actual end date changed from 9 Feb 2007 to Mar 2007 as reported by ClinicalTrials.gov.
    • 12 Nov 2007 Results, including the primary endpoint, from these two trials were presented at the 2007 Annual Meeting of the American Academy of Opthalmology, held in New Orleans, Louisiana, USA.
    • 12 Nov 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top